Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 75   

Articles published

ARNA 4.17 +0.07 (1.71%)
price chart
Belviq Sales Dip: What To Watch For Ahead
Sales of the Arena Pharmaceuticals (NASDAQ:ARNA) anti-obesity pill Belviq seem to be seeing some impacts of seasonality with ups and downs as the Fall weeks progress.
Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl ...
WOODCLIFF LAKE, N.J. and SAN DIEGO, Oct. 13, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that data from the Phase 3 clinical trial program for BELVIQ� (lorcaserin HCl) CIV will be presented at the ...
Related articles »  
Eisai and Arena Pharmaceuticals Announce Publication of Pooled Phase 3 ...
WOODCLIFF LAKE, N.J. and SAN DIEGO, Oct. 10, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that a pooled analysis of the BLOOM and BLOSSOM pivotal, Phase 3 clinical trials of BELVIQ� ...
Belviq Sales Rise Almost 5% Week Over Week  Seeking Alpha (registration)
Related articles »  
Momentum Stocks: Ariad Pharmaceuticals Inc. (ARIA), Arena Pharmaceuticals ...
The average volume for Ariad Pharmaceuticals Inc. (NADSAQ:ARIA) has been 7.4 million shares per day over the past 30 days. Ariad Pharmaceuticals Inc. (NADSAQ:ARIA) stock opened with a price of $5.65 and hit a high of $5.68 with a low of $5.55 today.
News Recap � CYS Investments (CYS), Arena Pharmaceuticals, Inc. (ARNA ...
CYS Investments Inc (NYSE:CYS) declared financial results for the quarter ended June 30, 2014. June 30, 2014 book value per common share of $10.31 after declaring a $0.32 dividend per common share on June 9, 2014, compared to our book value of ...
Related articles »  
Investor Updates : Auxilium Pharma , Avanir Pharma , Arena Pharma , Novavax ...
Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) : On October 2, Meeting held at Boston hosted by Jefferies. Auxilium (AUXL) downgraded to Sector Perform from Outperform at RBC Capital.
Related articles »  
Mid Day Alert: Neuralstem, Inc. (NYSEMKT:CUR), Arena Pharmaceuticals, Inc ...
Lakeway, NY - (MARKET NEWS CALL) - 10/20/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Don't Miss : Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Caterpillar Inc ...
Contrave is a combination of two Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Vivus Inc. drugs that were approved by the FDA in 2012, ABC News reports, after having spent 13 years without approving any weight-loss medication.
Volatile Stocks in List: Gilead Sciences, Inc.(NASDAQ:GILD), Arena ...
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) with OODCLIFF LAKE, N.J. and SAN DIEGO declared on last Friday session that a group analysis of the BLOOM and BLOSSOM pivotal, Phase 3 clinical trials of BELVIQ� (lorcaserin HCl) was printed in the ...
Related articles »  
Today's Watch List: Arena Pharmaceuticals (NASDAQ:ARNA), Advanced Micro ...
On 10 October Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai Inc announced that a pooled analysis of the BLOOM and BLOSSOM pivotal, Phase 3 clinical trials of BELVIQ� (lorcaserin HCl) was published in the October issue of Postgraduate ...